thelancetoncol.bsky.social
The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9. 🌐 https://www.thelancet.com/journals/lanonc/home
👤 Joined on 03 February 2025
Followers
Following
Total Posts
@thelancetoncol.bsky.socialExcited to see this work on the cost of cancer published today in @thelancetoncol.bsky.social! Fantastic to work with @healthdatainsight.bsky.social to bring together cancer registration, diagnostic and treatment datasets @england.nhs.uk www.sciencedirect.com/science/arti... @auhe-leeds.bsky.social
Show Post(2/2) This will help ensure that readers are able to make well-informed clinical decisions in the best interest of patients. Read The Lancet Oncology’s full Comment and new editorial guidelines: tinyurl.com/4nztpej3 @thelancetoncol.bsky.social #CommonSenseOncology #CancerCare
Show Post(1/2) In an important development for the oncology community, The Lancet Oncology & other Lancet family specialty journals are adopting new rigorous standards for clinical trials reporting, consistent with the CSO Checklist. @thelancetoncol.bsky.social #CommonSenseOncology #CancerCare
Show PostWe are excited to team up with @thelancetoncol.bsky.social, @TheLancetPublicHealth and @IARCWHO for: #IARC60 Cancer Research into Action Conference Lyon, France, 19-21 May, 2026 Submit your abstract by 19 Jan, 2026: iarc2026conf.iarc.who.int/en/abstracts... For more: iarc2026conf.iarc.who.int
Show Post🤩 🤝 Looking forward to welcoming the Editor-in-Chief of The Lancet Oncology David Collingridge at #NMN2026: www.nmn-society.org! @thelancetoncol.bsky.social www.thelancet.com/journals/lan...
Show Post